| 1 |
32940862 | Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERĪ² and IL-6/gp130/STAT3 signaling. | 2021 Feb |
1 |
| 2 |
29714141 | Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells. | 2019 |
1 |
| 3 |
28430601 | Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling. | 2017 May 16 |
4 |
| 4 |
28711499 | Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. | 2017 Sep 9 |
1 |
| 5 |
24456369 | Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface. | 2014 Feb 13 |
3 |